Enabling Pharma Companies to Launch AI That Holds Up to Regulatory Scrutiny
How to move beyond pilots and deploy AI systems that are credible, controllable, and inspection-ready. Artificial Intelligence is no longer a “future capability” in pharma – it’s becoming an operational lever across discovery, clinical development, manufacturing, and post-market safety. But pharma isn’t a sector where “move fast and break things” is acceptable. When AI influences […]
